TipHub

₹311.7

▼ -0.75 -0.24%

As of 28 Jul 2026 · delayed

NSE Listed · Pharmaceuticals

Wanbury Limited (WANBURY)

Volume: 2,85,158Avg Vol 1W: 2,75,290Avg Vol 1M: 7,34,10352W Range:₹161.5₹358.85
NSE BSE www.wanbury.com AI Report
Key Ratios
Checked 9h ago
Market Cap₹1,092 Cr
Current Price₹311.7
Previous Close₹312.45
High / Low (52w)₹358.85 / ₹161.5
Volume2,85,158
Avg Vol (1W)2,75,290
Avg Vol (1M)7,34,103
Stock P/E43.04
Book Value₹22.16
Dividend Yield0%
ROE51.51%
ROA10.39%
Revenue (TTM)—
Revenue Growth3.77%
Profit Margin6.83%
Total Debt₹160 Cr
Shares Outstanding3 Cr
Face Value₹10
EPS (TTM)₹12.3
P/B14.1
Debt / Equity3.38
50 DMA₹287.67
200 DMA₹253.17
Day change-0.24%
Price Chart
₹311.7▲ 23.57% · 1Y
₹345₹16376.4L
2025-07-29
2026-07-28

20-day avg volume: 7.9L shares

Pros
  • Healthy return on equity of 51.5%.
  • Company is almost debt-free.
  • Net profit is growing year over year.
Quarterly Results
MetricSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025
Revenue₹144 Cr₹146 Cr₹139 Cr₹131 Cr₹161 Cr₹133 Cr₹172 Cr₹163 Cr
EBITDA₹15 Cr₹19 Cr₹16 Cr₹9 Cr₹18 Cr₹11 Cr₹28 Cr₹21 Cr
Net Profit₹7 Cr₹10 Cr₹34 Cr₹1 Cr₹8 Cr₹1 Cr₹20 Cr₹13 Cr
EPS————————
Profit & Loss (Annual)
MetricSept 2024Dec 2024Mar 2025Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹161 Cr₹133 Cr₹603 Cr₹172 Cr₹163 Cr₹160 Cr₹162 Cr₹165 Cr
EBITDA₹18 Cr₹11 Cr₹67 Cr₹28 Cr₹21 Cr₹22 Cr₹23 Cr₹27 Cr
Net Profit₹8 Cr₹1 Cr₹31 Cr₹20 Cr₹13 Cr₹15 Cr₹16 Cr₹22 Cr
EPS——8.98—————
Balance Sheet
MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Total Assets₹273 Cr₹286 Cr₹279 Cr₹289 Cr₹353 Cr₹304 Cr₹343 Cr₹414 Cr
Total Liabilities₹457 Cr₹495 Cr₹422 Cr₹445 Cr₹376 Cr₹336 Cr₹316 Cr₹355 Cr
Equity₹-185 Cr₹-209 Cr₹-143 Cr₹-156 Cr₹-23 Cr₹-33 Cr₹28 Cr₹59 Cr
Total Debt————————
Cash Flow
MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating₹33 Cr₹30 Cr₹44 Cr₹18 Cr₹41 Cr₹20 Cr₹4 Cr₹26 Cr
Investing₹-1 Cr₹-3 Cr₹64 Cr₹8 Cr₹1 Cr₹-9 Cr₹-17 Cr₹-51 Cr
Financing₹-33 Cr₹-27 Cr₹-108 Cr₹-17 Cr₹-29 Cr₹-32 Cr₹15 Cr₹26 Cr
Free Cash Flow₹31 Cr₹25 Cr₹36 Cr₹13 Cr₹31 Cr₹7 Cr₹-13 Cr₹-23 Cr
Shareholding
Promoter 43.02% Institutions 0.96% Public 56.03%
Efficiency & Working Capital
ROCE28%
Interest Coverage1.9
Dividend Payout—
Debtor Days70 d
Inventory Days23 d
Payable Days84 d
Cash Conversion Cycle8 d
Working Capital Days92 d
Shareholding Details

As of 2026-06-30

Promoter43%
FII0.9%
DII0.1%
Institutions1%
Public56%
Promoter Pledge86.7%
No. of Shareholders17,174
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Promoters39.8%39.8%39.8%39.8%39.8%39.8%39.8%39.6%43.1%43.1%43%43%
FIIs0%0%0.2%0.2%1%0.8%1.6%1.6%0.8%0.7%0.6%0.9%
DIIs0%0.1%0%0%0%0%0%0%0%0%0%0.1%
Public60.2%60.1%60%60%59.2%59.4%58.7%58.8%56.1%56.2%56.4%56%
Promoter Pledge76.7%76.7%71.1%76.7%76.7%76.7%76.7%76.7%86.7%86.7%86.7%86.7%
No. of Shareholders11,63411,61613,08714,40017,19917,99917,88917,89417,71717,26116,73217,174
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202503————
Major Shareholders (>1%)
NameCategoryStakeShares
Expert Chemicals (india) Pvt LtdShareholding of Promoter and Promoter Group34.4%1.20 Cr
Kingsbury Investments IncShareholding of Promoter and Promoter Group8.7%30,24,000
Suresh BhatiaPublic Shareholding3.1%10,87,795
Authum Investment And Infrastructure LimitedPublic Shareholding2.1%7,22,865
Zaki Abbas NasserPublic Shareholding1.8%6,15,000
Sharmin NasserPublic Shareholding1.3%4,65,000
Basava Sankararao KolliPublic Shareholding1.2%4,05,399
Promoter Pledges
HolderPledged Shares% of HoldingAs of
Expert Chemicals (india) Pvt Ltd93,46,07377.9%2026-06-30
Board of Directors
NameDesignationYear
K ChandranE D & Wholetime Director2025
Mohan Kumar RayanaWTD & Executive Director2025
Anupam VaidyaIndependent Non Exe. Director2025
Mridul Sumanlal MehtaIndependent Non Exe. Director2025
MANOJKUMAR KHUBCHAND GURSAHANIIndependent Non Exe. Director2025
Pallavur Sankar Dass VaidyanathanIndependent Non Exe. Director2025
Jitendra J GandhiCompany Sec. & Compli. Officer2025
Segments — Product
SegmentRevenueShare
Pharmaceutical₹0 Cr—
Segments — Geography
RegionRevenueShare
India₹204 Cr40.3%
Outside India₹303 Cr59.7%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2025₹10503333
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
202530030—
2025300306
2025300306
Insider / Designated-Person Trades

1 recent disclosure(s)

SBICAP Trustee Company LimitedRevoke · 91,72,561
Substantial Acquisitions (SAST)

1 disclosure(s)

Release of Shares25/07/2025 · —
Company Information
Incorporated1988
AuditorKapoor & Parekh Associates
Investor Email[email protected]; [email protected]
🌐 www.wanbury.com ↗

📍 BSEL Tech Park B-Wing 10th Flr, Sector 30 A Opp Vashi Rly Stat, Navi Mumbai, Maharashtra, 400703

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

Indosolar LimitedWaaree Renewable Technologies Ltd.VA Tech Wabag Ltd.Wakefit Innovations Ltd.Walchandnagar Industries Ltd.Walpar Nutritions LimitedWestern Carriers (Ind) LimitedWealth First Portfolio Managers Ltd.Websol Energy System Ltd.Weizmann Ltd.Wonder Electricals Ltd.Welspun Corp LimitedAll “W” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search